Pages that link to "Q33243576"
Jump to navigation
Jump to search
The following pages link to Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. (Q33243576):
Displaying 50 items.
- Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression (Q21135459) (← links)
- Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle (Q21562299) (← links)
- Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors (Q22308631) (← links)
- Major issues and challenges of influenza pandemic preparedness in developing countries (Q24646958) (← links)
- Current and future antiviral therapy of severe seasonal and avian influenza (Q24656164) (← links)
- Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants (Q27650620) (← links)
- Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance (Q28282405) (← links)
- Antiviral resistance and the control of pandemic influenza (Q28469119) (← links)
- Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses (Q28473051) (← links)
- Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam (Q28473743) (← links)
- Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates (Q28475369) (← links)
- Influenza Virus Non-Structural Protein 1 (NS1) Disrupts Interferon Signaling (Q28748500) (← links)
- Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011. (Q30218773) (← links)
- Avian influenza A H5N1 virus: a continuous threat to humans (Q30224462) (← links)
- Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target (Q30227194) (← links)
- Risk assessment of H2N2 influenza viruses from the avian reservoir (Q30355580) (← links)
- Avian influenza: are our feathers ruffled? (Q30355804) (← links)
- New vaccines against influenza virus. (Q30357932) (← links)
- Role of combination antiviral therapy in pandemic influenza and stockpiling implications. (Q30359766) (← links)
- Avian influenza virus (H5N1): a threat to human health. (Q30361041) (← links)
- A model to control the epidemic of H5N1 influenza at the source. (Q30365792) (← links)
- Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. (Q30366819) (← links)
- What the paediatrician needs to know when pandemic influenza arrives in clinical practice. (Q30367126) (← links)
- Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China (Q30367318) (← links)
- Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel. (Q30369353) (← links)
- Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. (Q30374227) (← links)
- Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding (Q30374356) (← links)
- A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. (Q30374413) (← links)
- Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. (Q30376004) (← links)
- Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. (Q30378572) (← links)
- Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance. (Q30379476) (← links)
- Pandemic influenza vaccines. (Q30380902) (← links)
- Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008. (Q30382408) (← links)
- Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. (Q30383545) (← links)
- Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. (Q30383771) (← links)
- Avian influenza--a review for doctors in travel medicine. (Q30386119) (← links)
- In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses (Q30387420) (← links)
- Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice (Q30388253) (← links)
- Update on antivirals and vaccines for seasonal and potential pandemic use. (Q30389265) (← links)
- 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication (Q30389518) (← links)
- Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles (Q30390753) (← links)
- Biological fitness and natural selection of amantadine resistant variants of avian influenza H5N1 viruses (Q30395981) (← links)
- Laninamivir and its Prodrug, CS-8958: Long-Acting Neuraminidase Inhibitors for the Treatment of Influenza (Q30396669) (← links)
- Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro (Q30397287) (← links)
- Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008 (Q30404038) (← links)
- Influenza : clinical symptoms, diagnostics and therapy (Q30405546) (← links)
- Novel vaccines against influenza viruses. (Q30407716) (← links)
- A(H5N1) Virus Evolution in South East Asia (Q30408089) (← links)
- Anti-influenza virus effect of aqueous extracts from dandelion (Q30410636) (← links)
- Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium (Q30413673) (← links)